Healthcare provider profile · identity verified

Angela K Farrington, NP

Nurse Practitioner · MINNEAPOLIS, MN · NPI 1568498913

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Warfarin Sodium	Warfarin Sodium	319	11
Sertraline Hcl	Sertraline Hcl	316	33
Jantoven	Warfarin Sodium	275	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	257	29
Oxycodone Hcl	Oxycodone Hcl	225	67
Furosemide	Furosemide	209	32
Lisinopril	Lisinopril	204	29
Amlodipine Besylate	Amlodipine Besylate	201	33
Gabapentin	Gabapentin	180	22
Trazodone Hcl	Trazodone Hcl	164	27
Quetiapine Fumarate	Quetiapine Fumarate	163	21
Potassium Chloride	Potassium Chloride	161	23
Omeprazole	Omeprazole	143	18
Metoprolol Succinate	Metoprolol Succinate	138	19
Lorazepam	Lorazepam	134	22
Donepezil Hcl	Donepezil Hcl	128	17
Losartan Potassium	Losartan Potassium	121	18
Hydromorphone Hcl	Hydromorphone Hcl	109	15
Atorvastatin Calcium	Atorvastatin Calcium	107	21
Nystatin	Nystatin	106	42
Pregabalin	Pregabalin	98	13
Pantoprazole Sodium	Pantoprazole Sodium	94	11
Memantine Hcl	Memantine Hcl	83	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	78	suppressed
Simvastatin	Simvastatin	75	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	71	11
Tramadol Hcl	Tramadol Hcl	68	22
Olanzapine	Olanzapine	65	11
Citalopram Hbr	Citalopram Hydrobromide	64	suppressed
Bumetanide	Bumetanide	63	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	59	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	54	28
Tamsulosin Hcl	Tamsulosin Hcl	52	suppressed
Mirtazapine	Mirtazapine	50	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	suppressed
Loperamide	Loperamide Hcl	49	26
Buspirone Hcl	Buspirone Hcl	48	suppressed
Divalproex Sodium	Divalproex Sodium	44	suppressed
Metformin Hcl	Metformin Hcl	44	suppressed
Ondansetron Hcl	Ondansetron Hcl	44	24
Morphine Sulfate	Morphine Sulfate	42	17
Eliquis	Apixaban	40	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	suppressed
Hydralazine Hcl	Hydralazine Hcl	39	suppressed
Levetiracetam	Levetiracetam	39	suppressed
Xarelto	Rivaroxaban	36	suppressed
Spironolactone	Spironolactone	35	suppressed
Carvedilol	Carvedilol	34	suppressed
Hydrocortisone	Hydrocortisone	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	17
Doxycycline Hyclate	Doxycycline Hyclate	32	19
Methadone Hcl	Methadone Hcl	30	suppressed
Prednisone	Prednisone	30	18
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	29	29
Famotidine	Famotidine	29	suppressed
Klor-Con M20	Potassium Chloride	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	11
Methocarbamol	Methocarbamol	27	suppressed
Albuterol Sulfate	Albuterol Sulfate	26	20
Albuterol Sulfate Hfa	Albuterol Sulfate	26	suppressed
Atenolol	Atenolol	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Nystop	Nystatin	25	14
Trimethoprim	Trimethoprim	25	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	24	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	24	suppressed
Cephalexin	Cephalexin	23	19
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Haloperidol	Haloperidol	23	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Metolazone	Metolazone	22	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Metformin Hcl Er	Metformin Hcl	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Rexulti	Brexpiprazole	19	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	18	suppressed
Rytary	Carbidopa/Levodopa	17	suppressed
Torsemide	Torsemide	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	suppressed
Fentanyl	Fentanyl	16	suppressed
Finasteride	Finasteride	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Rivastigmine	Rivastigmine	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Nyamyc	Nystatin	13	suppressed
Ropinirole Er	Ropinirole Hcl	13	suppressed
Sulfasalazine	Sulfasalazine	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Valsartan	Valsartan	13	suppressed
Allopurinol	Allopurinol	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Glipizide	Glipizide	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error